Clinical Trial Update: Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update reports on rapamycin therapy for patients with tuberous sclerosis complex and sporadic lymphangioleiomyomatosis; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphangioleiomyomatosis
• Tuberous Sclerosis Complex

Drugs mentioned

• Rapamycin (sirolimus)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Tuberous Sclerosis, Lymphangioleiomyomatosis | Phase 2 | Status: COMPLETED